Literature DB >> 28716460

Ten Most Important Things to Know About Caring for Transgender Patients.

Stuart R Chipkin1, Fred Kim2.   

Abstract

Transgender people have a gender that is not in agreement with their birth sex. Previous barriers, including lack of provider knowledge, have created significant healthcare disparities for this population. Recent societal changes are increasing the numbers of transgender people seen by primary care practitioners. Ten key principles are provided to help primary care practitioners create more welcoming environments and provide quality care to transgender patients. Overall, all members of the healthcare team (primary and specialty) need to become aware of the transition process and maintain communication regarding risks, benefits, and goals. Transwomen (aka male to female) can be treated with estrogens, antiandrogens, or a combination. Benefits include change in fat distribution, skin softening, and breast development. Significant risks for thrombosis from estrogens have been linked to genetic mutations, smoking, prolonged inactivity, and hormone formulation. Oral administration may provide increased risk over peripheral administration. Transmen (aka female to male) can be treated with peripheral testosterone preparations. Benefits include deepening of voice and development of facial and body hair with variable changes in muscle mass. Risks from testosterone appear to be less common than from estrogen. Laboratory monitoring can guide treatment decisions and provide early detection of some complications. Monitoring of "existing" anatomy (either hormonally or surgically created or removed) is an important component of healthcare for transgender patients. Primary care providers also should be aware of resources in their community and online, which can help patients optimize their transition.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cross-sex hormone therapy; Female to male; Male to female; Transgender; Transsexual

Mesh:

Year:  2017        PMID: 28716460     DOI: 10.1016/j.amjmed.2017.06.019

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Stroke Risk Factors Unique to Women.

Authors:  Stacie L Demel; Steven Kittner; Sylvia H Ley; Mollie McDermott; Kathryn M Rexrode
Journal:  Stroke       Date:  2018-02-08       Impact factor: 7.914

2.  Perspectives on expertise in teaching about transgender healthcare: A focus group study with health professional programme teaching staff and transgender community members.

Authors:  Gareth J Treharne; Althea Gamble Blakey; Katie Graham; Samuel D Carrington; Laurel A McLachlan; Cassie Withey-Rila; Louise Pearman-Beres; Lynley Anderson
Journal:  Int J Transgend Health       Date:  2021-02-08

3.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

Review 4.  The Evolving Role of Pharmacists in Transgender Health Care.

Authors:  Jan S Redfern; Michael W Jann
Journal:  Transgend Health       Date:  2019-04-11

5.  Longitudinal Changes in Hematologic Parameters Among Transgender People Receiving Hormone Therapy.

Authors:  Ana Antun; Qi Zhang; Shalender Bhasin; Andrew Bradlyn; W Dana Flanders; Darios Getahun; Timothy L Lash; Rebecca Nash; Douglas Roblin; Michael J Silverberg; Vin Tangpricha; Suma Vupputuri; Michael Goodman
Journal:  J Endocr Soc       Date:  2020-08-25

6.  Mapping evidence on the effects of gender-affirming hormone therapy on the hard and soft tissues of the craniofacial complex in transgender people: a protocol for a scoping review.

Authors:  M F Van den Bosch; C M Wiepjes; M Den Heijer; L J Schoonmade; R E G Jonkman; R A Meursinge Reynders
Journal:  Syst Rev       Date:  2021-04-14

7.  Navigating Human Immunodeficiency Virus and Primary Care Concerns Specific to the Transgender and Gender-Nonbinary Population.

Authors:  Mark Lieber; Matthew M Hamill; Paul Pham; Elyse Pine; Jill Crank; Maunank Shah
Journal:  Open Forum Infect Dis       Date:  2022-03-23       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.